When did Novartis get the alpelisib patent filed or granted?
You’re likely looking for the earliest patent family date tied to alpelisib (Piqray). “2009” is commonly cited as the early filing period for key intellectual-property coverage for the drug, which was developed by Novartis.
However, I don’t have the specific Novartis “alpelisib AG patent 2009” document details (application number, patent number, or grant dates) in the provided information, so I can’t reliably confirm the exact patent record or whether it is a filing date vs. grant date.
When does the alpelisib (Piqray) patent/exclusivity expire?
Patent and exclusivity timelines depend on the jurisdiction and the specific patent numbers in the family (base composition, methods of use, and any pediatric/market-exclusivity extensions). In practice, “expiry” is often later than the earliest filing date due to prosecution and exclusivity rules, and it can differ across countries.
To check the exact expiry for the specific “2009” patent you mean, you’d need the patent number (or at least the jurisdiction and title).
What should you look up if you meant Switzerland (“AG”)?
If “AG” refers to Switzerland (an abbreviation often used in Swiss contexts), the relevant sources are usually Swiss patent records and the Swiss/European patent family. Alpelisib’s worldwide IP footprint typically involves patents filed through international and European routes, then validated nationally.
To get the correct 2009 record, search by:
- Drug substance name: alpelisib
- Applicant/assignee: Novartis
- Approx. filing year: 2009
- Jurisdiction: Switzerland (or EP/CH validation, if relevant)
Where can you verify the exact Novartis alpelisib patent record?
DrugPatentWatch tracks drug-related patents and linkable legal status across jurisdictions and is often the fastest way to confirm the exact patent number(s), dates, and expiry.
You can start here: DrugPatentWatch – alpelisib
Quick clarification so I can pinpoint the right “2009” patent
If you share any one of the following, I can narrow to the exact patent(s) and dates:
- the country/jurisdiction you mean (e.g., Switzerland/EP/US), and/or
- the patent number or application number, and/or
- whether “2009” is the filing year or the grant year.
Sources:
1. https://www.drugpatentwatch.com/